Literature DB >> 21917963

The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.

Natalie Pica1, Arun Iyer, Irene Ramos, Nicole M Bouvier, Ana Fernandez-Sesma, Adolfo García-Sastre, Anice C Lowen, Peter Palese, John Steel.   

Abstract

We assessed the relative susceptibilities to disease of the DBA.2 and C57BL/6 mouse models upon infection with a range of influenza A and B viruses. DBA.2 mice were more susceptible to disease upon inoculation with human H1N1 influenza A virus strains, several swine influenza viruses, and influenza B viruses but were not overtly susceptible to infection with human seasonal H3N2 strains. Hemagglutination inhibition and immunoglobulin isotype profiling indicated that DBA.2 and C57BL/6 mice generate comparable humoral responses upon equivalent 50% mouse lethal dose (MLD(50)) challenges with influenza virus. Our data demonstrate the utility of DBA.2 mice for the elucidation of influenza virus pathogenicity determinants and the testing of influenza vaccines.

Entities:  

Mesh:

Year:  2011        PMID: 21917963      PMCID: PMC3209355          DOI: 10.1128/JVI.05930-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

2.  Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model.

Authors:  Adrianus C M Boon; Jennifer deBeauchamp; Scott Krauss; Adam Rubrum; Ashley D Webb; Robert G Webster; Janet McElhaney; Richard J Webby
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

3.  Effects of receptor binding specificity of avian influenza virus on the human innate immune response.

Authors:  Irene Ramos; Dabeiba Bernal-Rubio; Natasha Durham; Alan Belicha-Villanueva; Anice C Lowen; John Steel; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  A computer program for estimating LD50 and its confidence limits using modified Behrens-Reed-Muench cumulant method.

Authors:  A K Thakur; W L Fezio
Journal:  Drug Chem Toxicol       Date:  1981       Impact factor: 3.356

Review 5.  The 2009 A (H1N1) influenza virus pandemic: A review.

Authors:  Marc P Girard; John S Tam; Olga M Assossou; Marie Paule Kieny
Journal:  Vaccine       Date:  2010-05-27       Impact factor: 3.641

6.  Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data.

Authors:  Jonathan Dushoff; Joshua B Plotkin; Cecile Viboud; David J D Earn; Lone Simonsen
Journal:  Am J Epidemiol       Date:  2005-11-30       Impact factor: 4.897

7.  Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?

Authors:  Jianqiang Ye; Erin M Sorrell; Yibin Cai; Hongxia Shao; Kemin Xu; Lindomar Pena; Danielle Hickman; Haichen Song; Matthew Angel; Rafael A Medina; Balaji Manicassamy; Adolfo Garcia-Sastre; Daniel R Perez
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice.

Authors:  Adrianus C M Boon; Jennifer deBeauchamp; Anna Hollmann; Jennifer Luke; Malak Kotb; Sarah Rowe; David Finkelstein; Geoffrey Neale; Lu Lu; Robert W Williams; Richard J Webby
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

Review 10.  Making better influenza virus vaccines?

Authors:  Peter Palese
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more
  55 in total

1.  Residues in the PB2 and PA genes contribute to the pathogenicity of avian H7N3 influenza A virus in DBA/2 mice.

Authors:  Brittany L DesRochers; Rita E Chen; Anshu P Gounder; Amelia K Pinto; Traci Bricker; Camille N Linton; Corianne D Rogers; Graham D Williams; Richard J Webby; Adrianus C M Boon
Journal:  Virology       Date:  2016-04-20       Impact factor: 3.616

2.  Murine Model for the Study of Influenza D Virus.

Authors:  J Oliva; J Mettier; L Sedano; M Delverdier; N Bourgès-Abella; B Hause; J Loupias; I Pardo; C Bleuart; P J Bordignon; E Meunier; R Le Goffic; G Meyer; M F Ducatez
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

3.  Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.

Authors:  Hannah C Watkins; C Garrett Rappazzo; Jaclyn S Higgins; Xiangjie Sun; Nicole Brock; Annie Chau; Aditya Misra; Joseph P B Cannizzo; Michael R King; Taronna R Maines; Cynthia A Leifer; Gary R Whittaker; Matthew P DeLisa; David Putnam
Journal:  Mol Ther       Date:  2017-02-16       Impact factor: 11.454

4.  DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.

Authors:  Jin Il Kim; Sehee Park; Sangmoo Lee; Ilseob Lee; Jun Heo; Min-Woong Hwang; Joon-Yong Bae; Donghwan Kim; Seok-Il Jang; Mee Sook Park; Man-Seong Park
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

5.  Syrian Hamster as an Animal Model for the Study of Human Influenza Virus Infection.

Authors:  Kiyoko Iwatsuki-Horimoto; Noriko Nakajima; Yurie Ichiko; Yuko Sakai-Tagawa; Takeshi Noda; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

6.  Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.

Authors:  Almut H Vollmer; Makda S Gebre; Dale L Barnard
Journal:  Antiviral Res       Date:  2016-08-11       Impact factor: 5.970

7.  A broadly neutralizing human monoclonal antibody is effective against H7N9.

Authors:  Kannan Tharakaraman; Vidya Subramanian; Karthik Viswanathan; Susan Sloan; Hui-Ling Yen; Dale L Barnard; Y H Connie Leung; Kristy J Szretter; Tyree J Koch; James C Delaney; Gregory J Babcock; Gerald N Wogan; Ram Sasisekharan; Zachary Shriver
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 8.  Molecular determinants of influenza virus pathogenesis in mice.

Authors:  Ram P Kamal; Jaqueline M Katz; Ian A York
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Anti-influenza effect of Cordyceps militaris through immunomodulation in a DBA/2 mouse model.

Authors:  Hwan Hee Lee; Heejin Park; Gi-Ho Sung; Kanghyo Lee; Taeho Lee; Ilseob Lee; Man-seong Park; Yong Woo Jung; Yu Su Shin; Hyojeung Kang; Hyosun Cho
Journal:  J Microbiol       Date:  2014-07-18       Impact factor: 3.422

10.  Fecal influenza in mammals: selection of novel variants.

Authors:  Zeynep A Koçer; John Obenauer; Hassan Zaraket; Jinghui Zhang; Jerold E Rehg; Charles J Russell; Robert G Webster
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.